kilodalton glycoprotein that is expressed on the cell surface and in the cytoplasm. In 30 cases of acute and chronic leukaemia, Ber-MAC3 staining was restricted to 15 reactivity is restricted to the Methods Suspended mononuclear splenocytes (1 x 107) containing monocytes, macrophages, and B cells, were used for a weekly immunisation of balb/c mice over a period of six weeks. The spleen was obtained fresh from a normal donor after a traumatic rupture.
Somatic cell hybridisation was performed three days after the last immunisation according to the protocol of Oi and Herzenberg. 26 Supernatants from wells exhibiting hybrid growth were tested by immunoenzymatic staining with the alkaline phosphatase antialkaline phosphatase (APAAP) method27 on frozen sections of human tonsil and lymph node from a patient with Hodgkin's disease.
The immunoglobulin subclass of the monoclonal antibody was determined by double immunodiffusion using subclass specific rabbit anti-mouse reagents (Serotec, Wiesbaden, Germany).
All cells were cultured in RPMI medium (Biochrom, Berlin, Germany) containing 10% fetal calf serum (FCS) (Gibco, Berlin), 4 mM glutamine 10 U/ml penicillin, and 01 mg/ml streptomycin (Boehringer, Mannheim, Germany). Peripheral blood lymphocytes were prepared from anticoagulated blood by FicollHypaque density centrifugation. T cells were obtained by E-rosette formation using sheep red blood cells treated with 2-aminoethylisothiouronium-bromide-hydrobromide (AET Viable human alveolar macrophages were tritiated by the borohydride method36 and lysed with phosphate buffered saline (PBS) containing 1% Triton X-100 and 2 mM phenylmethyl-culfonylfluoride (PMSF) (Sigma). For internal labelling 6 x I07 cells of the DHL-I3 cell line were washed three times with methionine-free medium (Gibco) without FCS, then suspended in medium without methionine, containing 10% FCS (dialysed against methionine-free RPMI 1640) at a concentration of 1 x 106 cells/ml and incubated for 30 minutes at 37°C and 5% carbondioxide. Then 1 mCi 35S-methionine (NEN-Dupont, Dreieich, Germany) was added and the cells were incubated for 20 hours. Cells were harvested, washed three times with medium containing methionine (Gibco), and the cell pellet was lysed in PBS containing 0-02% NaN3 (Merck, Darmstadt, Germany), 1% NP40 (LKB, Bromma, Sweden), and 1 mM PMSF (Sigma) for 2 hours at 4°C. The antigen was precipitated from the cell lysate as well as from cell culture supernatant. Immunoprecipitation was performed according to Schwarting et al.1
The molecular weight of the target antigen was determined by running the precipitates from alveolar macrophages on a 5%-20% polyacrylamide gradient gel and by running the DHL-1 cell precipitates on a 10% polyacrylamide gel.
FUNCTIONAL ANALYSIS
Investigation of the chemoluminescence response was performed using the modified method of Kato.38 Cells for detection of chemoluminescence were suspended in chemoluminescence medium (DMEM containing 50 mM of HEPES, pH 7-4, without NaHCO3 and phenol red (Boehringer)). Luminol (Boehringer) was dissolved in PBS (2 mg/ml), supplemented with 8 pl triethylamin/ ml (Kato) . Zymosan particles (Sigma) were suspended at a concentration of 50 mg/ml. Latex beads (1 1 pm diameter) were adjusted to 6 x 109 particles/ml chemoluminescence medium. A 0-1 mM solution of FMLP (Sigma) was used. Sheep erythrocytes optimally sensitised with rabbit IgG anti-E antibodies were obtained from Cordis, Miami, USA. The concentration of red cells was 108/ml. Chemoluminescence was measured in a sixchannel luminescence measuring device (LB 9505, Berthold, Wildbad, Germany) at 37°C.
Cell suspensions (300 p1) were mixed with I lp1 of luminol solution. Phagocytosis was started after two minutes of chemoluminescence background recording by adding 10 p1 of phagocytosis stimulus. The data continuously obtained were displayed and recorded on line (Apple II computer).
The chemoluminescence response was measured with untreated monocytes as control and with monocytes incubated with Ber-MAC3 ascites (diluted 1 in 100, 1 in 200, and 1 in 500), Fab fragments, and purified immunoglobulin (1-150 Mg/ml). Purified immunoglobulins were obtained by using the Bio-Rad Affi-Gel Protein A MAPS-II Kit (Bio-Rad, Richmond, California, USA).
For preparation of Fab fragments, purified immunoglobulins were diluted at a concentra- (table 6) , and none of cell line U937 and the monocytic leukaemia cell the other myeloid leukaemias belonging to the line THP-1 with TPA and IFN-G for 14 days According to the molecular weight and binding pattern to cell lines and a wide range of tissues, Ber-MAC3 seems to be different from all reported macrophage antibodies. Ber-MAC3 resembled other monocyte/macrophage-specific antibodies in its strong binding to macrophages, but differed from these in its molecular weight and in its non-reactivity with granulocytes or monocytes, most starry sky macrophages, epithelioid type macrophages and multinucleated macrophages, lymphoid subpopulations, TPA-treated cells of the HL60, THP1, and U937 cell lines, follicular dendritic cells and interdigitating reticulum cells. The only monoclonal antibody that shows a tissue binding similar to that seen with Ber-MAC3 is Ki-M8. The latter, however, differs from Ber-MAC3 in precipitating an antigen of lower molecular weight (30 and 32 kilodaltons), by its reactivity with the TPAstimulated U937 and HL60 cell line and giant cells, as well as its inhibitory effect on the generation of reactive oxidants.' Table 7 Reactivity of Ber-MAC3 with established human cell lines The only two solid neoplasms with which Ber-MAC3 gave a strongly positive reaction were the two cases of true histiocytic malignancies. This selective reactivity of Ber-MAC3 with histiocytic tumours in conjunction with its strong binding to the histiocytic lymphoma line DHL-1 shows the value of Ber-MAC3 for identifying neoplasms of true histiocytic origin.
In summary, Ber-MAC3 seems to distinguish between activated and non-activated monocytes, as well as between common tissue macrophages on the one hand, and starry sky macrophages, epithelioid type, and multinucleated type macrophages on the other hand. Ber-MAC3 is a suitable reagent for the diagnosis of myelomonocytic and monocytic leukaemias (M4/M5 subtype), as well as for the distinction of non-histiocytic neoplasms from those of true histiocytic origin. Thus Ber-MAC3 may be of interest for studies aimed at elucidating the regulation of differentiation of normal and neoplastic cells of the mononuclear phagocyte system and for the correlation of monocyte/macrophage functions with differentiation. 
